Oxytrol Transdermal Patch - Biweekly 3.9Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Oxytrol: Transdermal patch - Biweekly (3.9mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Oxytrol 3.9mg/24hr Patch

What is this Medicine?

OXYBUTYNIN (ox i BYOO ti nin) is used to treat overactive bladder. This medicine reduces the amount of bathroom visits. It may also help to control wetting accidents.

CVS Pharmacy Patient Statistics for Oxytrol: Transdermal patch - Biweekly(3.9mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Oxytrol 3.9mg/24hr Transdermal Patch

NDC: 525440920
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Neurogenic Bladder, Urinary Incontinence, Overactive Bladder (OAB)

Storage Information
Store in original package until time of use
Protect from moisture
Avoid excessive humidity
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Oxytrol 3.9mg/24hr Transdermal Patch

Reported Side Effects for Oxytrol 3.9mg/24hr Transdermal Patch

Excessive Thirst Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Skin Irritation Incidence:
1.0-6.4%*
Severity: MILD
Onset: EARLY
Cough Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Dry Nose Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Bladder Infection Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Hoarseness Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Heartburn Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Flushing Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
1.0-7.9%*
Severity: MILD
Onset: EARLY
Breathing Difficulties Incidence:
1.0-4.9%*
Severity: SEVERE
Onset: RAPID
Blurred Vision Incidence:
1.0-9.6%*
Severity: MODERATE
Onset: EARLY
Painful Urination Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: EARLY
Vomiting Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Gas Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Hives Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Dry Eyes Incidence:
1.0-3.1%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.0-5.4%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Retaining Urine Incidence:
1.2-6.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
1.3-15.1%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
1.5-7.5%*
Severity: MILD
Onset: EARLY
Allergic Skin Reaction Incidence:
1.8%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
2.5%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
2.8-16.6%*
Severity: MILD
Onset: EARLY
Vesicular Rash Incidence:
3.2%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
3.3%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
3.7-8.3%*
Severity: MODERATE
Onset: EARLY
Dry Mouth Incidence:
4.1-71.4%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.5-11.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Oxytrol 3.9mg/24hr Transdermal Patch

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Oxytrol 3.9mg/24hr Transdermal Patch(Oxybutynin)
Grapefruit juice and Oxybutynin(Oxybutynin)
Grapefruit juice and grapefruit-containing foods may increase the side effects of Oxybutynin. Do not significantly increase grapefruit juice intake while taking this drug, or avoid grapefruit juice if possible. Discuss any new or worsening side effects, such as confusion, constipation, dizziness, difficulty with urination, drowsiness, dry mouth and eyes, changes in vision, palpitations, or fast heartbeat with your health care provider. Do not drive or operate machinery until you know how these drugs affect you.
Moderate Lifestyle Interaction
Alcohol and Oxytrol 3.9mg/24hr Transdermal Patch(Oxybutynin)
Alcohol and Oxybutynin(Oxybutynin)
Do not drink Alcoholic beverages while taking Oxybutynin (Ditropan). You may feel drowsy or more tired if you drink alcohol-containing drinks while taking Oxybutynin. Do not drive or operate machinery while drinking Alcoholic beverages and until you know how Oxybutynin affects you. You may also notice an increase in the frequency of urination while taking Oxybutynin and drinking alcoholic beverages.
Minor Lifestyle Interaction
Caffeine-containing Foods/Beverages and Oxytrol 3.9mg/24hr Transdermal Patch(Oxybutynin)
Caffeine-containing Foods/Beverages and Oxybutynin(Oxybutynin)
The intake of beverages containing caffeine may decrease the actions of Oxybutynin because Caffeine may increase urination. You may wish to limit your caffeine intake (including intake of coffee, colas, teas, or herbal supplements) while taking oxybutynin.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Oxytrol

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.